Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer

Abstract

Somatic mutations are a major source of cancer development, and many driver mutations have been identified in protein coding regions. However, the function of mutations located in microRNAs (miRNAs) and their target binding sites throughout the human genome remains largely unknown. Here, we built detailed cancer-specific miRNA regulatory networks across 30 cancer types to systematically analyze the effect of mutations in miRNAs and their target sites in 3’ UTR, CDS, and 5’ UTR regions. A total of 3,518,261 mutations from 9,819 samples were mapped to miRNA-gene interactions (mGI). Mutations in miRNAs showed a mutually exclusive pattern with mutations in their target genes in almost all cancer types. A linear regression method identified 148 candidate driver mutations that can significantly perturb miRNA regulatory networks. Driver mutations in 3’UTRs played their roles by altering RNA binding energy and the expression of target genes. Finally, mutated driver gene targets in 3’ UTRs were significantly downregulated in cancer and functioned as tumor suppressors during cancer progression, suggesting potential miRNA candidates with significant clinical implications. A user-friendly, open-access web portal (mGI-map) was developed to facilitate further use of this data resource. Together, these results will facilitate novel non-coding biomarker identification and therapeutic drug design targeting the miRNA regulatory network.

Targeting Reprogrammed Cancer-Associated Fibroblasts with Engineered Mesenchymal Stem Cell Extracellular Vesicles for Pancreatic Cancer Treatment

“…MicroRNAs (miRNAs), which are a class of endogenous small noncoding RNAs, negatively regulate gene expression by inducing translational repression or mRNA decay [ 18 ]. In pancreatic cancer, miRNA dysregulation is associated with a broad spectrum of cellular processes.…”

Self-Powered Biosensor Based on DNA Walkers for Ultrasensitive MicroRNA Detection

“…MicroRNAs (miRNAs) are noncoding single-stranded RNAs containing 21∼25 nucleotides, which have a crucial impact in the adjustment of gene representation at the translational level. − At present, a number of research results have indicated that the improper expression of miRNAs is closely related with the etiopathogenesis of many cancers. , For example, the maladjusted expression of miRNA Let-7a and miRNA-21 is intensely relevant with early breast cancer . The abnormal expression of miRNA-141 could be an indicator for the development of prostate cancer, and miRNA-155 is closely correlated with cervical cancer .…”

Dysregulated expression of microRNA involved in resistance to osimertinib in EGFR mutant non-small cell lung cancer cells

“…MicroRNAs (miRNAs), a family of small noncoding RNA molecules of approximately 20-22 nucleotides in length, are essential to the regulation of multiple biological processes, including gene regulation, apoptosis, and maintenance of cell differentiation (19,20). In particular, miRNAs play a key role in regulating gene expression, and miRNAs are commonly dysregulated in cancer (21,22). In terms of lung cancer, miRNAs can be used as diagnostic and prognostic markers, and have a dual role in indicating carcinogenesis and behavior (23)(24)(25).…”